Matches in SemOpenAlex for { <https://semopenalex.org/work/W2270727283> ?p ?o ?g. }
- W2270727283 endingPage "1656" @default.
- W2270727283 startingPage "1649" @default.
- W2270727283 abstract "Background The continued presence of biofilm may be one cause of the high risk of failure observed with irrigation and débridement with component retention in acute periprosthetic joint infection (PJI). There is a poor understanding of the role of biofilm antibiotic tolerance in PJI. Questions/purposes (1) Do increasing doses of cefazolin result in decreased viable biofilm mass on arthroplasty materials? (2) Is cefazolin resistance phenotypic or genotypic? (3) Is biofilm viability a function of biofilm depth after treatment with cefazolin? (4) Is the toxin-antitoxin system, yoeB expression, associated with antibiotic stress? Methods Methicillin-sensitive Staphylococcus aureus biofilm was cultured on total knee arthroplasty (TKA) materials and exposed to increasing doses of cefazolin (control, 0.5, 1.0, 10.0, 100.0 μg/mL). Quantitative confocal microscopy and quantitative culture were used to measure viable biofilm cell density. To determine if cefazolin resistance was phenotypic or genotypic, we measured minimum inhibitory concentration (MIC) after exposure to different cefazolin concentrations; changes in MIC would suggest genotypic features, whereas unchanged MIC would suggest phenotypic behavior. Finally, quantitative reverse transcription-polymerase chain reaction was used to quantify expression of yoeB levels between biofilm and planktonic bacteria after exposure to 1 μg/mL cefazolin for 3 hours. Results Although live biofilm mass was reduced by exposure to cefazolin when compared with biofilm mass in controls (39.2 × 103 ± 26.4 × 103 pixels), where the level after 0.5 μg/mL exposure also showed reduced mass (20.3 × 103 ± 11.9 × 103 pixels), no further reduction was seen after higher doses (mass at 1.0 μg/mL: 5.0 × 103 pixels ± 1.1 × 103 pixels; at 10.0 μg/mL: 6.4 × 103 ± 9.6 × 103 pixels; at 100.0 μg/mL: 6.4 × 103 ± 3.9 × 103). At the highest concentration tested (100 μg/mL), residual viable biofilm was present on all three materials, and there were no differences in percent biofilm survival among cobalt-chromium (18.5% ± 15.1%), polymethylmethacrylate (22.8% ± 20.2%), and polyethylene (14.7% ± 10.4%). We found that tolerance was a phenotypic phenomenon, because increasing cefazolin exposure did not result in changes in MIC as compared with controls (MIC in controls: 0.13 ± 0.02; at 0.5 μg/mL: 0.13 ± 0.001, p = 0.96; at 1.0 μg/m: 0.14 ± 0.04, p = 0.95; at 10.0 μg/m: 0.11 ± 0.016, p = 0.47; at 100.0 μg/m: 0.94 ± 0.047, p = 0.47). Expression of yoeB after 1 μg/mL cefazolin for 3 hours in biofilm cells was greater in biofilm but not in planktonic cells (biofilm: 62.3-fold change, planktonic cells: −78.8-fold change, p < 0.001). Conclusions Antibiotics are inadequate at complete removal of the biofilm from the surface of TKA materials. Results suggest that bacterial persisters are responsible for this phenotypic behavior allowing biofilm high tolerance to antibiotics. Clinical Relevance Antibiotic-tolerant biofilm suggests a mechanism behind the poor results in irrigation and débridement for acute TKA PJI." @default.
- W2270727283 created "2016-06-24" @default.
- W2270727283 creator A5002557578 @default.
- W2270727283 creator A5039728572 @default.
- W2270727283 creator A5042855723 @default.
- W2270727283 creator A5042963506 @default.
- W2270727283 creator A5056699722 @default.
- W2270727283 creator A5057499766 @default.
- W2270727283 creator A5067452387 @default.
- W2270727283 creator A5073956337 @default.
- W2270727283 creator A5084220653 @default.
- W2270727283 date "2016-07-01" @default.
- W2270727283 modified "2023-10-16" @default.
- W2270727283 title "Antibiotic-tolerant Staphylococcus aureus Biofilm Persists on Arthroplasty Materials" @default.
- W2270727283 cites W110946835 @default.
- W2270727283 cites W111016879 @default.
- W2270727283 cites W1595295429 @default.
- W2270727283 cites W1707025384 @default.
- W2270727283 cites W1921075021 @default.
- W2270727283 cites W1925542960 @default.
- W2270727283 cites W1967283397 @default.
- W2270727283 cites W1980159179 @default.
- W2270727283 cites W1982958351 @default.
- W2270727283 cites W2003324857 @default.
- W2270727283 cites W2016912614 @default.
- W2270727283 cites W20182019 @default.
- W2270727283 cites W2023096051 @default.
- W2270727283 cites W2044079597 @default.
- W2270727283 cites W2046355400 @default.
- W2270727283 cites W2051584259 @default.
- W2270727283 cites W2051834151 @default.
- W2270727283 cites W2055220708 @default.
- W2270727283 cites W2055411163 @default.
- W2270727283 cites W2066658503 @default.
- W2270727283 cites W2070502444 @default.
- W2270727283 cites W2081041927 @default.
- W2270727283 cites W2102175293 @default.
- W2270727283 cites W2108244474 @default.
- W2270727283 cites W2111057193 @default.
- W2270727283 cites W2113186567 @default.
- W2270727283 cites W2127817798 @default.
- W2270727283 cites W2133145520 @default.
- W2270727283 cites W2137010791 @default.
- W2270727283 cites W2166606642 @default.
- W2270727283 cites W2171922048 @default.
- W2270727283 cites W4320578144 @default.
- W2270727283 doi "https://doi.org/10.1007/s11999-016-4720-8" @default.
- W2270727283 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4887357" @default.
- W2270727283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26831479" @default.
- W2270727283 hasPublicationYear "2016" @default.
- W2270727283 type Work @default.
- W2270727283 sameAs 2270727283 @default.
- W2270727283 citedByCount "70" @default.
- W2270727283 countsByYear W22707272832016 @default.
- W2270727283 countsByYear W22707272832017 @default.
- W2270727283 countsByYear W22707272832018 @default.
- W2270727283 countsByYear W22707272832019 @default.
- W2270727283 countsByYear W22707272832020 @default.
- W2270727283 countsByYear W22707272832021 @default.
- W2270727283 countsByYear W22707272832022 @default.
- W2270727283 countsByYear W22707272832023 @default.
- W2270727283 crossrefType "journal-article" @default.
- W2270727283 hasAuthorship W2270727283A5002557578 @default.
- W2270727283 hasAuthorship W2270727283A5039728572 @default.
- W2270727283 hasAuthorship W2270727283A5042855723 @default.
- W2270727283 hasAuthorship W2270727283A5042963506 @default.
- W2270727283 hasAuthorship W2270727283A5056699722 @default.
- W2270727283 hasAuthorship W2270727283A5057499766 @default.
- W2270727283 hasAuthorship W2270727283A5067452387 @default.
- W2270727283 hasAuthorship W2270727283A5073956337 @default.
- W2270727283 hasAuthorship W2270727283A5084220653 @default.
- W2270727283 hasBestOaLocation W22707272831 @default.
- W2270727283 hasConcept C141071460 @default.
- W2270727283 hasConcept C2778120723 @default.
- W2270727283 hasConcept C2778336525 @default.
- W2270727283 hasConcept C2778353156 @default.
- W2270727283 hasConcept C2779489039 @default.
- W2270727283 hasConcept C501593827 @default.
- W2270727283 hasConcept C523546767 @default.
- W2270727283 hasConcept C54355233 @default.
- W2270727283 hasConcept C58123911 @default.
- W2270727283 hasConcept C71924100 @default.
- W2270727283 hasConcept C86803240 @default.
- W2270727283 hasConcept C89423630 @default.
- W2270727283 hasConcept C94665300 @default.
- W2270727283 hasConceptScore W2270727283C141071460 @default.
- W2270727283 hasConceptScore W2270727283C2778120723 @default.
- W2270727283 hasConceptScore W2270727283C2778336525 @default.
- W2270727283 hasConceptScore W2270727283C2778353156 @default.
- W2270727283 hasConceptScore W2270727283C2779489039 @default.
- W2270727283 hasConceptScore W2270727283C501593827 @default.
- W2270727283 hasConceptScore W2270727283C523546767 @default.
- W2270727283 hasConceptScore W2270727283C54355233 @default.
- W2270727283 hasConceptScore W2270727283C58123911 @default.
- W2270727283 hasConceptScore W2270727283C71924100 @default.
- W2270727283 hasConceptScore W2270727283C86803240 @default.
- W2270727283 hasConceptScore W2270727283C89423630 @default.
- W2270727283 hasConceptScore W2270727283C94665300 @default.